Parvovirus B19-associated graft failure after allogeneic hematopoietic stem cell transplantation

被引：6
|
作者：
Rattani, Nabila [1 ]
Matheny, Christina [1 ]
Eckrich, Michael J. [1 ]
Madden, Lisa M. [1 ]
Quigg, Troy C. [1 ,2 ]
机构：
[1] Methodist Childrens Hosp, Texas Transplant Inst, Pediat Blood & Marrow Transplantat Program, San Antonio, TX USA
[2] Helen DeVos Childrens Hosp, Pediat Blood & Marrow Transplantat Program, 10th Floor MC185,100 Michigan St NE, Grand Rapids, MI 49503 USA
来源：
CANCER REPORTS | 2022年 / 5卷 / 01期
关键词：
allogeneic hematopoietic stem cell transplantation; graft failure; parvovirus B19 infection;
D O I：
10.1002/cnr2.1403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the literature is limited. Case Two pediatric patients were diagnosed with PVB19 infection around the time of allo-HSCT graft failure. Both cases were secondary graft failure and required second allo-HSCT. Conclusion There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo-HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo-HSCT graft failure.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Graft failure after allogeneic hematopoietic stem cell transplantation
    Ozdemir, Zehra Narli
    Bozdag, Sinem Civriz
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 163 - 167
  • [2] Graft failure after allogeneic hematopoietic cell transplantation
    Mattsson, Jonas
    Ringden, Olle
    Storb, Rainer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 165 - 170
  • [3] Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation
    Locatelli, Franco
    Lucarelli, Barbarella
    Merli, Pietro
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) : 23 - 36
  • [4] Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation
    Servais, Sophie
    Beguin, Yves
    Baron, Frederic
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (02) : 173 - 192
  • [5] Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors
    Alcazer, Vincent
    de Latour, Regis Peffault
    Ader, Florence
    Labussiere-Wallet, Helene
    BULLETIN DU CANCER, 2019, 106 (06) : 574 - 583
  • [6] Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
    SN Wolff
    Bone Marrow Transplantation, 2002, 29 : 545 - 552
  • [7] Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation
    Koda, Y.
    Mori, T.
    Kato, J.
    Kohashi, S.
    Kikuchi, T.
    Mitsuhashi, T.
    Murata, M.
    Uemura, T.
    Handa, M.
    Okamoto, S.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (06) : E239 - E242
  • [8] Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure
    Remberger, Mats
    Mattsson, Jonas
    Olsson, Richard
    Ringden, Olle
    CLINICAL TRANSPLANTATION, 2011, 25 (01) : E68 - E76
  • [9] Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
    Wolff, SN
    BONE MARROW TRANSPLANTATION, 2002, 29 (07) : 545 - 552
  • [10] The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation
    Riddell, SR
    Berger, C
    Murata, M
    Randolph, S
    Warren, EH
    BLOOD REVIEWS, 2003, 17 (03) : 153 - 162
12345